Page last updated: 2024-09-03

gr 73632 and ly686017

gr 73632 has been researched along with ly686017 in 1 studies

Compound Research Comparison

Studies (gr 73632)	Trials (gr 73632)	Recent Studies (post-2010) (gr 73632)	Studies (ly686017)	Trials (ly686017)	Recent Studies (post-2010) (ly686017)
77	1	9	6	2	1

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gehlert, DR; Iyengar, S; Kielbasa, W; Marek, G; Mozley, D; Peng, X; Tauscher, J; Vandenhende, F	1

Trials

1 trial(s) available for gr 73632 and ly686017

Article	Year
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:2 Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Dose-Response Relationship, Drug; Gerbillinae; Humans; Male; Neurokinin-1 Receptor Antagonists; Paroxetine; Peptide Fragments; Pyridines; Radioligand Assay; Radionuclide Imaging; Receptors, Neurokinin-1; Stereotyped Behavior; Substance P; Treatment Outcome; Triazoles	2010

Article

Year

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:2

Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Dose-Response Relationship, Drug; Gerbillinae; Humans; Male; Neurokinin-1 Receptor Antagonists; Paroxetine; Peptide Fragments; Pyridines; Radioligand Assay; Radionuclide Imaging; Receptors, Neurokinin-1; Stereotyped Behavior; Substance P; Treatment Outcome; Triazoles

2010